title: Jejunitis secondary to Duodopa® probe, a different complication.
abstract: Treatment with continuous infusion of intraduodenal (Duodopa®) levodopa / carbidopa is indicated in patients with advanced Parkinson's disease who have not responded to conventional treatment. We present here the case of a patient with this type of probe that debuted jejunitis. A distal phytobezoar was the main causal agent. This rare complication may be favored in cases of intestinal hypomotility. Treatment involves its withdrawal as soon as possible and replacement by a new probe, which results in healing.
authors.affiliation: Aparato Digestivo, Hospital Universitario Puerta de Hierro Majadahonda. Madrid, ESPAÑA.
authors.forename: Marta
authors.initials: M
authors.lastname: Magaz Martínez
authors.affiliation: Hospital Universitario Puerta de Hierro Majadahonda. Madrid.
authors.forename: José Luis
authors.initials: JL
authors.lastname: Martínez Porras
authors.affiliation: Hospital Universitario Puerta de Hierro Majadahonda. Madrid.
authors.forename: Borja
authors.initials: B
authors.lastname: Oliva
authors.affiliation: Ap. Digestivo, Hospital Universitario Puerta de Hierro, España.
authors.forename: Luis
authors.initials: L
authors.lastname: Abreu
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001630:Bezoars; D002230:Carbidopa / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D016099:Endoscopy, Gastrointestinal; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable / Q000009:adverse effects*; D007579:Jejunal Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy
chemical_list: D000978:Antiparkinson Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa